Alvotech Disclosed The Resubmission To The U.S. Food And Drug Administration Of Biologics License Applications For Avt05, A Proposed Biosimilar To Simponi And Simponi Aria (Golimumab), And Avt06, A Proposed Biosimilar To Eylea (Aflibercept) 2 Mg

뉴스 본문을 불러오고 있어요.

Alvotech Disclosed The Resubmission To The U.S. Food And Drug Administration Of Biologics License Applications For Avt05, A Proposed Biosimilar To Simponi And Simponi Aria (Golimumab), And Avt06, A Proposed Biosimilar To Eylea (Aflibercept) 2 Mg | 웨이프 WAPE

Alvotech Disclosed The Resubmission To The U.S. Food And Drug Administration Of Biologics License Applications For Avt05, A Proposed Biosimilar To Simponi And Simponi Aria (Golimumab), And Avt06, A Proposed Biosimilar To Eylea (Aflibercept) 2 Mg

기사 요약

관련 종목

댓글 —